IMNM
Price
$21.71
Change
-$0.62 (-2.78%)
Updated
Dec 26 closing price
Capitalization
2.4B
82 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$19.30
Change
-$0.06 (-0.31%)
Updated
Dec 26 closing price
Capitalization
1.96B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs NRIX

Header iconIMNM vs NRIX Comparison
Open Charts IMNM vs NRIXBanner chart's image
Immunome
Price$21.71
Change-$0.62 (-2.78%)
Volume$1.04M
Capitalization2.4B
Nurix Therapeutics
Price$19.30
Change-$0.06 (-0.31%)
Volume$794.35K
Capitalization1.96B
IMNM vs NRIX Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. NRIX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and NRIX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (IMNM: $21.71 vs. NRIX: $19.30)
Brand notoriety: IMNM and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 51% vs. NRIX: 40%
Market capitalization -- IMNM: $2.4B vs. NRIX: $1.96B
IMNM [@Biotechnology] is valued at $2.4B. NRIX’s [@Biotechnology] market capitalization is $1.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 3 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than NRIX.

Price Growth

IMNM (@Biotechnology) experienced а +1.26% price change this week, while NRIX (@Biotechnology) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.4B) has a higher market cap than NRIX($1.96B). IMNM YTD gains are higher at: 104.426 vs. NRIX (2.442). IMNM has higher annual earnings (EBITDA): -231.45M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. IMNM (273M). IMNM has less debt than NRIX: IMNM (4.01M) vs NRIX (56.5M). NRIX has higher revenues than IMNM: NRIX (83.7M) vs IMNM (9.68M).
IMNMNRIXIMNM / NRIX
Capitalization2.4B1.96B122%
EBITDA-231.45M-248.7M93%
Gain YTD104.4262.4424,277%
P/E RatioN/AN/A-
Revenue9.68M83.7M12%
Total Cash273M429M64%
Total Debt4.01M56.5M7%
TECHNICAL ANALYSIS
Technical Analysis
IMNMNRIX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFAPX27.080.05
+0.18%
Morgan Stanley Inst Intl Advtg A
RYTCX7.43N/A
N/A
Royce Small-Cap Total Return Consult
KVALX12.83N/A
N/A
Kennedy Capital Small Cap Value Instl
VQNPX68.12-0.01
-0.01%
Vanguard Growth & Income Inv
AFOZX21.24-0.08
-0.38%
Alger Mid Cap Focus Z

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-2.78%
KURA - IMNM
54%
Loosely correlated
-3.89%
IDYA - IMNM
53%
Loosely correlated
-1.35%
VYGR - IMNM
53%
Loosely correlated
+0.25%
NRIX - IMNM
51%
Loosely correlated
-0.31%
RLAY - IMNM
50%
Loosely correlated
-1.04%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-0.31%
KYMR - NRIX
65%
Loosely correlated
-2.18%
XNCR - NRIX
55%
Loosely correlated
-1.49%
KURA - NRIX
55%
Loosely correlated
-3.89%
SYRE - NRIX
54%
Loosely correlated
-0.33%
OCUL - NRIX
53%
Loosely correlated
-1.18%
More